PNL12 COST UTILITY ANALYSIS OF INTERFERON BETA-1A (AVONEX) IN PRE-CLINICALLY DEFINITE MULTIPLE SCLEROSIS (CDMS)
May 1, 2004, 00:00
10.1016/S1098-3015(10)62285-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)62285-1/fulltext
Title :
PNL12 COST UTILITY ANALYSIS OF INTERFERON BETA-1A (AVONEX) IN PRE-CLINICALLY DEFINITE MULTIPLE SCLEROSIS (CDMS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62285-1&doi=10.1016/S1098-3015(10)62285-1
First page :
Section Title :
Open access? :
No
Section Order :
223